Literature DB >> 2894699

Tardive psychosis: does it exist?

T Palmstierna1, B Wistedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2894699     DOI： 10.1007/bf00735897

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs.

Authors:  U Ungerstedt; T Ljungberg
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  Supersensitivity and clozapine withdrawal.

Authors:  K Eklund
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Neuroleptic-induced supersensitivity psychosis.

Authors:  G Chouinard; B D Jones; L Annable
Journal:  Am J Psychiatry       Date:  1978-11       Impact factor: 18.112

4.  Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

Authors:  P Hartvig; S A Eckernäs; L Lindström; B Ekblom; U Bondesson; H Lundqvist; C Halldin; K Någren; B Långström
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Authors:  G Chouinard; B D Jones
Journal:  Am J Psychiatry       Date:  1980-01       Impact factor: 18.112

6.  Absence of acquired tolerance to neuroleptics in schizophrenic patients.

Authors:  T Palmstierna; B Wistedt
Journal:  Am J Psychiatry       Date:  1987-08       Impact factor: 18.112

7.  Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.

Authors:  B Wistedt; J Ranta
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal.

Authors:  B Ekblom; K Eriksson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.

Authors:  G Gardos; J O Cole; R M Rapkin; R A LaBrie; E Baquelod; P Moore; R Sovner; J Doyle
Journal:  Arch Gen Psychiatry       Date:  1984-11

10.  Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.

Authors:  T Kolakowska; A O Williams; M Ardern; M A Reveley; K Jambor; M G Gelder; B M Mandelbrote
Journal:  Br J Psychiatry       Date:  1985-03       Impact factor: 9.319
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.